Dadident · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dadident is 0.1% (very low). The 2025 annual accounts show equity of €231k and a net result of €214k. Equity is growing by ~19.7% per year across the filed fiscal years. Its solvency ranks better than 38% of 2219 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-05-2026, 87 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	05-05-2026	87 d early	2026-00102558
31-12-2024	31-07-2025	09-07-2025	22 d early	2025-00251835
31-12-2023	31-07-2024	26-06-2024	35 d early	2024-00166480
31-12-2022	31-07-2023	26-07-2023	5 d early	2023-00273242

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2021, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.1% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€214k-15.5%

Working capital€-38k

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 05-05-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~19.7%/year over 4 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	37.0%	58.2%	better than 38% of 2219 sector peers
Net result	€214k	€60k	better than 91% of 2217 sector peers
Equity	€231k	€74k	better than 81% of 2219 sector peers
Gross operating margin	€438k	€95k	better than 95% of 2219 sector peers
Staff costs	€86k	€22k	higher than 91% of 362 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P38

Improving position over 2022-2025 · n=2219-6584

Net result P91

Stable position over 2022-2025 · n=2217-6578

Equity P81

Stable position over 2022-2025 · n=2219-6584

Gross operating margin P95

Stable position over 2022-2025 · n=2219-6586

Describes the position versus peers, not a forecast.

EBITDA

€349k

-13.3% 22-25

Net profit

€214k

-15.5% 22-25

Cash flow

€286k

-12.1% 22-25

Total assets

€624k

-41.2% 22-25

Equity

€231k

-71.4% 22-25

Working capital

€-38k

- 22-25

Employees (FTE)

2

+66.7% 22-25

Staff costs

€86k

+98.8% 22-25

Show 12 other metrics

Income taxes

€64k

-17.1% 22-25

Dividends

€790k

- 22-25

Debt

€393k

+55.1% 22-25

Debt ≤ 1y

€232k

+338.1% 22-25

Debt > 1y

€161k

-19.6% 22-25

Current ratio

0.83

-92.8% 22-25

Quick ratio

0.83

-92.8% 22-25

Solvency

37.0%

-51.4% 22-25

Debt / equity

1.70

+442.4% 22-25

ROE

92.9%

+195.3% 22-25

ROA

34.3%

+43.5% 22-25

Interest coverage

62.13

+3.3% 22-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€349k
Net profit	€214k
Cash flow	€286k
Staff costs	€86k
Income taxes	€64k
Dividends	€790k
Total assets	€624k
Equity	€231k
Debt	€393k
of which ≤ 1y	€232k
of which > 1y	€161k
Working capital	€-38k
Employees (FTE)	2.0

Ratios (computed)

	2025
Current ratio	0.83
Quick ratio	0.83
Working capital ratio	-6.2%
Solvency	37.0%
Debt / equity	1.70
Long-term debt ratio	0.70
Interest coverage	62.13
Gross margin	-
Net margin	-
ROA	34.3%
ROE	92.9%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €430k · 69.0% Current assets €193k · 31.0%

Equity & liabilities

Equity €231k · 37.0% Debt €393k · 63.0%

Full annual accounts (26 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€624k
Fixed assets	21/28	€430k
Intangible fixed assets	21	€599
Tangible fixed assets	22/27	€430k
Financial fixed assets	28	€125
Current assets	29/58	€193k
Amounts receivable within one year	40/41	€45k
Investments	50/53	€88k
Cash & bank	54/58	€57k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€624k
Equity	10/15	€231k
Contributions / capital	10/11	€10k
Reserves	13	€221k
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€393k
Amounts payable after one year	17	€161k
Amounts payable within one year	42/48	€232k
Trade debts payable within one year	44	€7k
Income statement
Gross operating margin	9900	€438k
Operating result	9901	€277k
Financial income	75	€7k
Financial charges	65	€6k
Result before taxes	9903	€279k
Income taxes	67/77	€64k
Net result for the period	9904	€214k
Result to be appropriated	9905	€214k

This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

58 / 100 Fair

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Beselarestraat 488890 Moorslede

Establishment units

1 location

Dadident

Beselarestraat 48, 8890 MoorsledeVervaardiging van medische en tandheelkundige instrumenten en benodigdheden

since 20212.326.373.269

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area1,277 m²

Buildings1

Building footprint230 m²

Volume (LiDAR)1,225 m³

Tallest building9.3 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
36003A0018/00L000	Flanders	1,277 m²	1 · 230 m²	9.3 m · 2 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Financial profile

5 of 5 axes measured

68 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 58

Profitability 100

Solvency 54

Growth 32

Stability 94

Credit advice

verdict per customer and amount

Similar

Similar companies

Comparable size, same sector

Tandartsenpraktijk De Bie

BE 0431.236.759 · Heist-op-den-Berg

Eq €231k→

Cabinet Dentaire Romane Schadeck

BE 0781.418.439 · Aywaille

Eq €231k→

JCMA

BE 0804.747.632 · Mons

Eq €232k→

Hazjos

BE 0788.397.687 · Leopoldsburg

Eq €229k→

CABINET DELCOUR - BINTEIN

BE 0770.553.845 · Kortrijk

Eq €228k→

We hold annual accounts for 1,196 of the 6,941 companies in this sector. 1,017 of them are within a factor 10 of this company's equity.

See full sector →

Company registry

Company registry (CBE)

Crossroads Bank

Activities

Tandartspraktijken86230Activiteiten van tandartspraktijken86230Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995

Primary activity highlighted.

Names & trade names

Legal nameNL

Dadident

Registered office

Beselarestraat 48

8890 Moorslede, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.